Advertisement
Advertisement

ENTA

ENTA logo

Enanta Pharmaceuticals, Inc

13.78
USD
Sponsored
-0.23
-1.64%
Apr 20, 16:00 UTC -4
Closed
exchange

After-Market

13.80

+0.02
+0.15%

Enanta Pharmaceuticals, Inc Profile

About

Enanta Pharmaceuticals, Inc. is a biotechnology company. It engages in the research and development of molecule drugs for the treatment of infectious diseases such as hepatitis C virus, respiratory tract infections, intravenous and oral treatments. Enanta Pharmaceuticals, Inc. is headquartered in Watertown, Massachusetts.

Info & Links

CEO

Jay R. Luly

Headquarters

4 KINGSBURY AVENUE
WATERTOWN, MA 02472, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.enanta.com

Auditor

PricewaterhouseCoopers LLP

Share holders

12

Employees

120

Enanta Pharmaceuticals, Inc Statistics

Valuation Measures

Market Capitalization2

400.47M

Enterprise Value

363.03M

Enterprise Value/EBITDA(ttm)

-5.32

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

6.04

Price to Book(mrq)

3.20

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-106.80%

Profit Margin(ttm)

-109.79%

Return on Equity(ttm)

-78.58%

Return on Invested Capital(ttm)

-85.56%

Return on Assets(ttm)

-23.18%

Income Statement

Revenue(ttm)

66.98M

Revenue Per Share(ttm)

2.31

Gross Profit(ttm)

66.98M

EBITDA(ttm)3

-68.24M

Net Income Available to Common(ttm)

-71.54M

Diluted EPS(ttm)

-3.20

Share Statistics

Beta (5Y Monthly)

0.99

52-Week Change

170.20%

S&P 500 52-Week Change

37.82%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

29.02M

Dividend Yield

0.00%

Float4

25.69M

% Held by Insiders

11.48%

% Held by Institutions

94.99%

Balance Sheet

Total Cash(mrq)

185.85M

Total Cash Per Share(mrq)

6.40

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.44%

Quick Ratio(mrq)

4.44%

Book Value Per Share(mrq)

4.36

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.41

Free Cash Flow(ytd)

-11.84M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement